1.Lovell, RM & Ford, AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10, 712–721.
2.Palsson, OS, Whitehead, WE, Van Tilburg, MA et al. (2016) Development and validation of the Rome IV diagnostic questionnaire for adults. Gastroenterology 150, 1481–1491.
3.Lacy, BE, Mearin, F, Chang, L et al. (2016) Bowel disorders. Gastroenterology 150, 1393–1407.
4National Institute for Health and Care Excellence (2017) NICE (2017 update): irritable bowel syndrome in adults: diagnosis and management (NICE guideline CG61) [NIfHC Excellence, editor]. https://www.nice.org.uk/guidance/cg61/resources.
5.Whelan, K, Martin, LD, Staudacher, HM et al. (2018) The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice. J Hum Nutr Diet 31, 239–255.
6.Shepherd, SJ, Parker, FC, Muir, JG et al. (2008) Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 6, 765–771.
7.Murray, K, Wilkinson-Smith, V, Hoad, C et al. (2014) Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 109, 110–119.
8.Tuck, CJ, Ross, LA, Gibson, PR et al. (2017) Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption. J Hum Nutr Diet 30, 73–82.
9.Major, G, Pritchard, S, Murray, K et al. (2017) Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome. Gastroenterology 152, 124–133.
10.Deiteren, A, de Wit, A, van der Linden, L et al. (2016) Irritable bowel syndrome and visceral hypersensitivity: risk factors and pathophysiological mechanisms. Acta Gastro-enterologica Belgica 1996–2007 79, 29–38.
11.Staudacher, HM, Lomer, MC, Anderson, JL et al. (2012) Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 142, 1510–1518.
12.Harvie, RM, Chisholm, AW, Bisanz, JE et al. (2017) Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs. World J Gastroenterol 23, 4632–4643.
13.Halmos, EP, Power, VA, Shepherd, SJ et al. (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146, 67–75.
14.Chumpitazi, BP, Cope, JL, Hollister, EB et al. (2015) Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 42, 418–427.
15.McIntosh, K, Reed, DE, Schneider, T et al. (2017) FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 66, 1241–1251.
16.Staudacher, H, Lomer, M, Farquharson, F et al. (2017) Diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and probiotic restores Bifidobacterium species: a randomized controlled trial. Gastroenterology 153, 936–947.
17.Böhn, L, Störsrud, S, Liljebo, T et al. (2015) Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 149, 1399–1407.
18.Eswaran, SL, Chey, WD, Han-Markey, T et al. (2016) A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 111, 1824–1832.
19.Hustoft, T, Hausken, T, Ystad, S et al. (2017) Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil 29, [Epublication 16 October 2016].
20.Patcharatrakul, T, Juntrapirat, A, Lakananurak, N et al. (2019) Effect of structural individual low-FODMAP dietary advice vs. brief advice on a commonly recommended diet on IBS symptoms and intestinal gas production. Nutrients 11, 2856.
21.Dionne, J, Ford, AC, Yuan, Y et al. (2018) A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol 113, 1290–1300.
22.Schumann, D, Klose, P, Lauche, R et al. (2018) Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Nutrition 45, 24–31.
23.Marsh, A, Eslick, E & Eslick, G (2016) Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 55, 897–906.
24.Halmos, EP, Christophersen, CT, Bird, AR et al. (2015) Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 64, 93–100.
25.Bennet, SMP, Bohn, L, Storsrud, S et al. (2018) Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut 67, 872–881.
26.Gibson, GR, Probert, HM, Van Loo, J et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259–275.
27.So, D, Whelan, K, Rossi, M et al. (2018) Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr 107, 965–983.
28.Pokusaeva, K, Fitzgerald, GF & van Sinderen, D (2011) Carbohydrate metabolism in Bifidobacteria. Genes Nutr 6, 285–306.
29.Wilson, B, Rossi, M, Kanno, T et al. (2020) β-Galactooligosaccharide in conjunction with low FODMAP diet improves irritable bowel syndrome symptoms but reduces fecal Bifidobacteria. Am J Gastroenterol (In the Press).
30.Staudacher, H, Ross, FS, Briscoe, ZM et al. (2015) Advice from a dietitian regarding the low FODMAP diet broadly maintains nutrient intake and does not alter fibre intake. Gut 64, A143–A144.
31.Eswaran, S, Dolan, RD, Ball, SC et al. (2020) The impact of a 4-week low-FODMAP and mNICE diet on nutrient intake in a sample of US adults with irritable bowel syndrome with diarrhea. J Acad Nutr Diet 120, 641–649.
32.Staudacher, HM, Ralph, FS, Irving, PM et al. (2020) Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet. J Acad Nutr Diet 120, 535–547.
33.Huijbregts, P, Feskens, E, Räsänen, L et al. (1997) Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and The Netherlands: longitudinal cohort study. Br Med J 315, 13–17.
34.O'keeffe, M, Jansen, C, Martin, L et al. (2018) Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol Motil 30, [Epublication 14 July 2017].
35.Bingham, SA, Gill, C, Welch, A et al. (1994) Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr 72, 619–643.
36.Prentice, RL, Mossavar-Rahmani, Y, Huang, Y et al. (2011) Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. Am J Epidemiol 174, 591–603.
37.Guadagnoli, L, Mutlu, EA, Doerfler, B et al. (2019) Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome. Qual Life Res 28, 2195–2205.
38.Bohn, L, Storsrud, S, Liljebo, TM et al. (2015) A randomized, controlled trial comparing a diet low in fodmaps with traditional dietary advice in patients with IBS. Gastroenterology 148, S654.
39.Eswaran, S, Chey, WD, Jackson, K et al. (2017) A diet low in fermentable oligo-, di-, and monosaccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea. Clin Gastroenterol Hepatol 15, 1890–1899.
40.de Roest, RH, Dobbs, BR, Chapman, BA et al. (2013) The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 67, 895–903.
41.Mazzawi, T, Hausken, T, Gundersen, D et al. (2013) Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Report 8, 845–852.
42.Ostgaard, H, Hausken, T, Gundersen, D et al. (2012) Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Report 5, 1382–1390.
43.Tuck, CJ, Reed, DE, Muir, JG et al. (2020) Implementation of the low FODMAP diet in functional gastrointestinal symptoms: a real-world experience. Neurogastroenterol Motil 32, [Epublication 30 September 2019].
44.Trott, N, Aziz, I, Rej, A et al. (2019) How patients with IBS use low FODMAP dietary information provided by general practitioners and gastroenterologists: a qualitative study. Nutrients 11, 1313.
45.Whigham, L, Joyce, T, Harper, G et al. (2015) Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 28, 687–696.
46.Chen, J, Lieffers, J, Bauman, A et al. (2017) The use of smartphone health apps and other mobile health (mHealth) technologies in dietetic practice: a three country study. J Hum Nutr Diet 30, 439–452.
47.Dimidi, E, Whelan, K, Lomer, MC (2020) Investigating optimal education regarding the low FODMAP diet in functional bowel disorders: a feasibility randomised controlled trial of leaflet vs mobile application vs dietetic consultation. Proc Nutr Soc 79 (OCE1), E7.
48.Valeur, J, Småstuen, MC, Knudsen, T et al. (2018) Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome. Dig Dis Sci 63, 429–436.
49.Rossi, M, Aggio, R, Staudacher, HM et al. (2018) Volatile organic compounds in feces associate with response to dietary intervention in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 16, 385–391.
50.Wilson, B, Rossi, M, Kanno, T et al. (2020) Low FODMAP diet & prebiotic β-galactooligosaccharides improve irritable bowel syndrome and response to low FODMAP is predicted by urine and faecal metabolites: a randomised controlled trial. Proc Nutr Soc 79 (OCE1), E19
51.McKenzie, YA, Bowyer, RK, Leach, H et al. (2016) British dietetic association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 29, 549–575.